BDSI

BDSI NASDAQ
4.590
+0.070
+1.55%
After Hours: 4.597 +0.007 +0.16% 16:11 05/21 EDT
Open
4.530
Prev Close
4.520
High
4.640
Low
4.510
Volume
864.14K
Avg Vol (3M)
1.07M
52 Week High
5.37
52 Week Low
2.175
% Turnover
0.99%
Market Cap
401.18M
1D
5D
1M
3M
1Y
5Y

Comments

No Data

Related

Webull offers BDSI BDSI stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

BioDelivery Sciences International, Inc. is a specialty pharmaceutical company. The Company develops and commercializes, either on its own or in partnerships with third parties, applications of approved therapeutics to address unmet medical needs using drug delivery technologies. The Company develops pharmaceutical products aimed principally in the areas of pain management and addiction. The Company's products utilize the BioErodible MucoAdhesive (BEMA) drug delivery technology, a small, erodible polymer film for application to the buccal mucosa (the lining inside the cheek). The Company's United Sates Food and Drug Administration (FDA) approved product, ONSOLIS (fentanyl buccal soluble film), as well as its approved products BUNAVAIL (buprenorphine and naloxone buccal film) buccal film and BELBUCA (buprenorphine) buccal film, utilize BEMA technology.
MORE >

Recently

Name
Price
%Change